Session III: Immunohematology: Platelets
Tracks
Plenary Hall
Sunday, September 7, 2025 |
1:45 PM - 2:50 PM |
Speaker
Dr. Mohamed Abuhaleeqa
Consultant, Hematology & Bone Marrow Transplant / Chair of Academic Affairs
Abu Dhabi Stem Cells Center
Gene Therapy in Thalassemia and SCD: Implementation Challenges and Long-Term Surveillance
1:45 PM - 2:00 PMBiography
Dr. Mohamed Abuhaleeqa is an esteemed Consultant in Hematology, Leukemia, and Bone Marrow Transplant. With a robust medical journey that includes qualifications from prestigious institutions and a specialization in Hematology, he is a dedicated healthcare leader. Dr. Abuhaleeqa's commitment to knowledge sharing is evident through his mentoring of junior doctors and his role as the Program Director for the Hematology Fellowship Program in the UAE. His extensive qualifications include FRCPSC in Leukemia and Bone Marrow Transplant, Hematology, and Internal Medicine, and he is registered with the College of Physicians and Surgeons of British Columbia. He is an active participant in seminars, symposiums, and research in hematology and a member of respected medical associations, including ASBMT, EBMT and CIBMTR, underscoring his dedication to healthcare advancement in the UAE.
Dr. Hani Osman
Consultant Clinical Hematologist
Tawam Hospital
Secondary TTP in Real-World Practice and Long-Term Outcomes
2:00 PM - 2:15 PMBiography
Dr. Hani Yousif Osman graduated from the Faculty of the Medicine University of Khartoum
Sudan. He moved to the United Kingdom where he completed his training in internal medicine
and obtained his MRCP (UK) degree. He completed his high specialist training in hematology at
the University of Cardiff hospital UK.
His research focuses on acute myeloid leukemia novel therapy, He has extensive hematology
consultant experience in the UK, Saudia Arabia, and the United Arab Emirates. Dr. Osman was
involved and the principal investigator for many clinical trials during his work in the UK.
Dr. Osman have more than 30 publications. He is an assistant professor of hematology in the
faculty of Medicine, United Arab Emirates University.
Dr. Amar Lal
Consultant Hematologist/Oncologist
Tawam Hospital
HIT: Guide to diagnosis and management
2:15 PM - 2:30 PMBiography
Dr. Amar Lal graduated from Dow University of Health Sciences in 1993. Subsequently he underwent medicine residency program for 4 years and followed by 3 years oncology fellowship. He qualified double FCPS degrees in medicine and oncology from College of Physicians and Surgeons, Pakistan (CPSP).
Then he got double diplomas from Royal Colleges of Physicians MRCP in medicine and oncology. He also qualified ESMO Examination Board in oncology.
He has been local and international speaker in hematology and oncology and has more than 20 publications.
Dr. Eman Taryam Alshamsi
Consultant and Acting Head of Pediatric Hematology Oncology Department
Al Jalila Children's Hospital
Updates on von Willebrand Disease and current Challenges in treatment and diagnosis
2:30 PM - 2:45 PMBiography
Dr. Eman Taryam AlShamsi is a Consultant and Acting Head of the Pediatric Hematology Oncology Department at Al Jalila Children’s Specialty Hospital, UAE. A UAE University graduate, she trained at Tawam Hospital and completed fellowships at SickKids, Toronto, and MD Anderson, Texas. She holds diplomas from the Arab Board, RCPCH, and Vienna School of Clinical Research. Dr. AlShamsi actively contributes to research, national cancer initiatives, and international collaborations, including SIOP and WLPO. She is a committed patient advocate and educator and was awarded the EOS Cancer Awareness Advocate of the Year 2024 by the Emirates Oncology Society.
Session Chair
Sana Al Blooshi
Haematology and Oncology Clinical Pharmacist
Tawam Hospital
Mozah AlMarshoodi
Acting Head of Medical Department
Sheikh Khalifa Hospital, Fujairah
